Creatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitative determination of creatine kinase (CK) in human serum and plasma. Catalog Number: 07190794190
Published October 2, 2024 · Recall initiated: August 15, 2024
Summary
FDA records medical device Class II recall Z-3187-2024, published October 2, 2024 and initiated August 15, 2024. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Ongoing; Reported quantity: 6504 units; Lot: UDI-DI: 04015630940806 Lot Number: 755471 Exp. Date: 06/30/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Creatine Kinase (CK) Assay Abnormal calibrations on the cobas® c 311/501/502 and COBAS INTEGRA 400 plus Analyzers may lead to erroneous results and misdiagnosis.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Distributor
- US Nationwide distribution.
- Lot
- UDI-DI: 04015630940806 Lot Number: 755471 Exp. Date: 06/30/2024
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAcobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, inNovember 27, 2024
- FDAThe device is a mobile x-ray system designed to work with Fujifilm's GOS and CsI scintillator FDR D-EVO2October 2, 2024
- FDASilver-Plated Copper Sims Uterine Sound, Part Number 64-600October 2, 2024
- FDAAlbumin Gen.2, Catalog 05166861190October 21, 2020
- FDAElecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virusDecember 18, 2019
- FDAOnline TDM Vancomycin Gen.3 (100 tests) Catalog # 06779336190 Analyzer/Module: cobas c 311 and cobas c 501/502October 16, 2019
Questions about this recall
Was Creatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitative determination of creatine kinase (CK) in human serum and plasma. Catalog Number: 07190794190 recalled?
Yes. FDA published recall Z-3187-2024 on October 2, 2024. Reported hazard: Creatine Kinase (CK) Assay Abnormal calibrations on the cobas® c 311/501/502 and COBAS INTEGRA 400 plus Analyzers may lead to erroneous results and misdiagnosis.
What should I do if I have this product?
Voluntary: Firm initiated · Letter